Neoadjuvant Treatment

Opdivo Receives Positive CHMP Opinion for Neoadjuvant Treatment of High-Risk NSCLC
SG Tylor
On May 26, 2023, Bristol Myers Squibb announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use ...